Condition (MeSH)
Thyroiditis, Autoimmune
ClinicalTrials.gov lists 73 trials for Thyroiditis, Autoimmune or a narrower condition beneath it. Sling Therapeutics, Inc. has the most among industry and government lead sponsors, with 3.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
27 of the 73 trials are tagged with Thyroiditis, Autoimmune itself; the rest are tagged with a narrower condition beneath it.
When did Thyroiditis, Autoimmune trials start? (22)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 2/3
- Phase 4
- Not applicable
- Observational
Top of scale: 8
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 6 |
| 2025 | 4 |
| 2024 | 3 |
| 2023 | 7 |
| 2022 | 4 |
| 2021 | 6 |
| 2020 | 8 |
| 2019 | 3 |
| 2018 | 4 |
| 2017 | 2 |
Showing 10 of 22 earlier years.
No forecast is made for this condition: it averages 4.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 35 months from start to primary completion across 7 trials still running at the 2026-10-09 snapshot; registered median of 14 months across 43 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Thyroiditis, Autoimmune trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 4 |
| Phase 2/3 | 3 |
| Phase 3 | 1 |
| Phase 4 | 4 |
| Not applicable | 29 |
| Observational | 30 |
How many Thyroiditis, Autoimmune trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 4 |
| Recruiting | 7 |
| Active, not recruiting | 1 |
| Completed | 44 |
| Terminated | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Thyroiditis, Autoimmune trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Sling Therapeutics, Inc. | 3 |
| TNF Pharmaceuticals, Inc. | 2 |
Which drugs are being tested for Thyroiditis, Autoimmune? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| OSI-906 | 3 |
| L-Selenomethionine | 2 |
Interventions as named in the registry (13)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Low Level Laser Therapy | 3 |
| Hydroxychloroquin | 2 |
| Treatment As Usual | 2 |
| Methimazole Pill | 2 |
| Test Euthyrox® | 1 |
Showing 5 of 13 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Thyroiditis, Autoimmune trials report? (4)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Electrocardiogram T Wave Abnormal | 1 | 1 |
| Guillain-Barre Syndrome | 1 | 1 |
| Pericardial Effusion | 1 | 1 |
| Pleural Effusion | 1 | 1 |
Which publications cover Thyroiditis, Autoimmune? (62)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Supplementation with active vitamin D3 ameliorates experimental autoimmune thyroiditis in mice by modulating the differentiation and functionality of intrathyroidal T-cell subsets. | Frontiers in immunology | 2025 | Yes |
| Thyroid autoimmunity and metabolic syndrome: a nationwide population-based study. | European journal of endocrinology | 2021 | Yes |
| Effects of exogenous melatonin on clinical and pathological features of a human thyroglobulin-induced experimental autoimmune thyroiditis mouse model. | Scientific reports | 2019 | Yes |
| Oxidative status in children and adolescents with autoimmune thyroiditis. | Clinical and experimental medicine | 2016 | Yes |
| Prevalence of Celiac Disease in Patients with Autoimmune Thyroid Disease: A Meta-Analysis. | Thyroid : official journal of the American Thyroid Association | 2016 | Yes |
Showing 5 of 62 publications.
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.